Sugar trackers on trial: can CGM help during C-Sections?

NCT ID NCT07671599

Not yet recruiting Knowledge-focused Sponsor: Icahn School of Medicine at Mount Sinai Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study will test whether continuous glucose monitors (CGMs) can accurately track blood sugar levels during scheduled C-sections in 150 women without diabetes. The goal is to understand normal glucose patterns during surgery and see if they relate to complications like wound infections. It is an early, exploratory study to gather data, not to test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Continuous Glucose Monitor (device)
What this could lead to: If successful, this could show that continuous glucose monitors are useful for tracking blood sugar during C-sections, potentially improving care for nondiabetic patients.
What could go wrong: This is a small, early pilot study with only 150 participants, so results may not apply to everyone. It is exploratory and not designed to prove any treatment benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DYSGLYCEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DYSGLYCEMIA

Contacts and locations

Locations

Icahn School of Medicine at Mount Sinai

New York, New York, 10029, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.